In this study, we examined the combined outcome of allele variation of the KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter on the drug resistance in the treatment of colon cancer and its underlying molecular mechanisms. This evidence concerns the gene KCNQ1OT1 and colonic neoplasm.